Histone H3.3 G34 mutations promote aberrant PRC2 activity and drive tumor progression | PNAS
A high percentage of pediatric gliomas and bone tumors reportedly harbor missense mutations at glycine 34 in genes encoding histone variant H3.3. W...
pnas.org